作者: Dana M. Evans , Jennifer M. Thorn , Katherine Arch-Douglas , Justin B. Sperry , Bruce Thompson
DOI: 10.1016/J.BIOLOGICALS.2016.02.001
关键词:
摘要: The United States Food and Drug Administration recently removed the requirement for a General Safety Test (GST) biologics in Code of Federal Regulations (21 CFR 610.11). GST, as well abnormal toxicity (European Pharmacopeia) innocuity tests (World Health Organization), were designed to test extraneous toxic contaminants on each product lot intended human use. Tests require one-week observations general health weight following injection specified volumes batches into guinea pigs mice. At specified, dose-related may result when is pharmacologically active rodents. With vaccines, required doses be > 3 logs higher than dose weight-adjusted basis if an immune modulatory adjuvant included, systemic hyperactivation cause toxicity. Herein, using CpG/alum combination we evaluated different protocols showed their unsuitability this combination.